[Congressional Record Volume 166, Number 218 (Monday, December 21, 2020)]
[Senate]
[Page S7929]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]




    EXPANDING FINDINGS FOR FEDERAL OPIOID RESEARCH AND TREATMENT ACT

  Mr. BOOZMAN. Mr. President, I ask unanimous consent that the Senate 
proceed to the immediate consideration of Calendar No. 510, H.R. 3153.
  The PRESIDING OFFICER. The clerk will report the bill by title.
  The legislative clerk read as follows:

       A bill (H.R. 3153) to direct the Director of the National 
     Science Foundation to support research on opioid addiction, 
     and for other purposes.

  There being no objection, the Senate proceeded to consider the bill, 
which had been reported from the Committee on Commerce, Science, and 
Transportation, with an amendment to strike all after the enacting 
clause and insert in lieu thereof the following

     SECTION 1. SHORT TITLE; FINDINGS.

       (a) Short Title.--This Act may be cited as the ``Expanding 
     Findings for Federal Opioid Research and Treatment Act'' or 
     the ``EFFORT Act''.
       (b) Findings.--The Congress finds that--
       (1) research gaps currently exist in the prevention and 
     treatment of opioid addiction;
       (2) the National Science Foundation's research on opioid 
     addiction has increased understanding of the neuroscience of 
     addiction, substance abuse intervention, the role of illicit 
     supply networks, the secondary effects on families, the use 
     of technology to address the opioid epidemic, and options for 
     alternative, non-addictive therapeutics for pain; and
       (3) the National Science Foundation and the National 
     Institutes of Health have recognized that fundamental 
     questions in basic, clinical, and translational research 
     would benefit greatly from multidisciplinary approaches and 
     collaboration.

     SEC. 2. NSF SUPPORT OF RESEARCH ON OPIOID ADDICTION.

       (a) In General.--The Direcor of the National Science 
     Foundation, in consultation with the Director of the National 
     Institutes of Health, shall support merit-reviewed and 
     competitively-awarded research on the science of opioid 
     addiction.
       (b) Authorization of Appropriations.--To carry out this 
     section, there are authorized to be appropriated $10,000,000 
     for each of fiscal years 2020 through 2024.
  Mr. BOOZMAN. I ask unanimous consent that the committee-reported 
substitute be withdrawn, the Wicker substitute amendment at the desk be 
agreed to, and the bill, as amended, be considered read a third time.
  The PRESIDING OFFICER. Is there objection?
  Without objection, it is so ordered.
  The committee-reported amendment in the nature of a substitute was 
withdrawn.
  The amendment (No. 2732) in the nature of a substitute was agreed to, 
as follows

                (Purpose: In the nature of a substitute)

       Strike all after the enacting clause and insert the 
     following:

     SECTION 1. SHORT TITLE; FINDINGS.

       (a) Short Title.--This Act may be cited as the ``Expanding 
     Findings for Federal Opioid Research and Treatment Act'' or 
     the ``EFFORT Act''.
       (b) Findings.--The Congress finds that--
       (1) research gaps currently exist in the prevention and 
     treatment of opioid addiction;
       (2) the National Science Foundation's research on opioid 
     addiction has increased understanding of the neuroscience of 
     addiction, substance abuse intervention, the role of illicit 
     supply networks, the secondary effects on families, the use 
     of technology to address the opioid epidemic, and options for 
     alternative, non-addictive therapeutics for pain; and
       (3) the National Science Foundation and the National 
     Institutes of Health have recognized that fundamental 
     questions in basic, clinical, and translational research 
     would benefit greatly from multidisciplinary approaches and 
     collaboration.

     SEC. 2. NSF SUPPORT OF RESEARCH ON OPIOID ADDICTION.

       The Director of the National Science Foundation, in 
     consultation with the Director of the National Institutes of 
     Health, shall support merit-reviewed and competitively 
     awarded research on the science of opioid addiction.

  The amendment was ordered to be engrossed and the bill to be read a 
third time.
  The bill was read the third time.
  Mr. BOOZMAN. I know of no further debate on the bill, as amended.
  The PRESIDING OFFICER. If there is no further debate, the bill having 
been read the third time, the question is, Shall the bill pass?
  The bill (H.R. 3153), as amended, was passed.
  Mr. BOOZMAN. I ask unanimous consent that the motion to reconsider be 
considered made and laid upon the table.
  The PRESIDING OFFICER. Without objection, it is so ordered.

                          ____________________